药物错误和药物释放规划中的差距对于住院的老年人:前性队列研究
Timothy S Anderson1,2, Linnea M Wilson3, Brianna X Wang3
1Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA. tsander@pitt.edu.
Journal of general internal medicine
|November 19, 2025
概括
由于心脏代谢药物的变化,老年人在出院后经常经历药物错误. 改进药物释放计划对于防止这些错误和确保患者安全至关重要.
科学领域:
- 老年医学 老年医学
- 临床药房 临床药房
- 患者安全 患者安全
背景情况:
- 住院的老年人经常在出院后改变心脏代谢药物.
- 药物不良事件是重新入院的重要原因之一.
- 关于药物出院计划沟通和出院后错误的数据有限.
研究的目的:
- 评估心脏代谢药物调整后老年人医院后的药物使用情况.
- 评估住院后的门诊随访护理与药物变化.
主要方法:
- 对65岁以上的成年人进行前性队列研究,其中包括心脏代谢药物变化.
- 关于药物使用,出院计划和健康状况的7天和90天的电话调查.
- 将自我报告的药物使用与出院总结进行比较,以识别错误.
主要成果:
- 151名参与者 (平均年龄74岁) 在出院时经历了平均2次药物变化.
- 33%的释放心脏代谢药物在90天内被修改.
- 39%的参与者在7天后出现了药物错误,在90天后增加到50%,只有13%的变化报告了全面的出院计划.
结论:
- 大多数因心脏代谢药物改变而出院的老年人会遇到药物错误.
- 对于这群人来说,在药物释放计划中存在显著的差距.
- 加强高质量的药物释放规划策略至关重要.
相关概念视频
Drug Dosing: Geriatric Patients
214
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
214
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
223
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
212
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
212
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
217
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
217
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
186
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
186


